BRCA1 and ovarian carcinoma: Prediction of genetic alterations: as already well known, in patients diagnosed with ovarian cancer it is critical to establish whether the BRCA-1 and BRCA-2 genes are mutated, since BRCA-mutated tumors are associated with increased chemosensitivity to platinum-based drugs resulting in increased PFS.